Toggle Navigation

Apply
Contact

Research
Back
Facilities
Back
Companies
Back
Education
Career
Back
- Open Positions
- Why Work Here
  Back
About
Back

Search

Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate

16 Dec'20

Valneva announced the initiation of a Phase 1/2 clinical study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.

Top

News
Research Groups
Events
Biotech Companies
Downloads
Job Offers
Cafeteria Menu
Contact

Vienna BioCenter
Campus-Vienna-Biocenter 1
1030 Vienna
Austria

© Vienna BioCenter

Legal Notice & Imprint

Cookies

The website uses cookies to ensure you get the best experience on our website.

Learn More

Analysis / statistics

( 1 Service )

Anonymous evaluation for troubleshooting and further development

no Analysis / statistics ( 1 Service )

yes

Google Ireland Limited

no Google Ireland Limited

yes

Google Ireland Limited Show details Hide details

Purpose: error analysis, statistical evaluation of our website accesses, campaign analysis, conversion tracking, retargeting
Processing operations: Collection of access data, data from your browser and data about the content accessed; Execution of analysis software and storage of data on your terminal device, anonymization of the data collected; Evaluation of the anonymous data in the form of statistics
Storage period: data on your device for up to two years.
Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland Legal basis for data processing: voluntary, consent that can be revoked at any time Consequences of non-consent: No direct impact on the functionality of the website; however limited opportunities for further development and error analysis
Data transfer to the USA: Your data is processed by the provider Google in the USA, which involves corresponding risks, e.g. B. a secret data access by US authorities. With your consent, you also consent to the processing of your data in the USA.